The global Point-of-Care Molecular Diagnostics market size in 2023 is 8407.8 million US dollars, and it is expected to be 10916.0 million US dollars by 2030, with a compound annual growth rate of 3.8% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Point-of-Care Molecular Diagnostics market include Abbott Laboratories, Inc., Roche Diagnostics, bioMérieux SA, Danaher Corporation (Beckman Coulter), and Cepheid (a subsidiary of Danaher Corporation). The share of the top 3 players in the Point-of-Care Molecular Diagnostics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Point-of-Care Molecular Diagnostics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. OTC accounted for XX% of Point-of-Care Molecular Diagnostics market in 2023. POC share of XX%.
Decentralized Labs accounted for XX% of the Point-of-Care Molecular Diagnostics market in 2023. Hospitals accounts for XX%.

This Point-of-Care Molecular Diagnostics market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Point-of-Care Molecular Diagnostics market country level analysis
The countries covered in the Point-of-Care Molecular Diagnostics market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Point-of-Care Molecular Diagnostics Market Share Analysis
Point-of-Care Molecular Diagnostics market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Point-of-Care Molecular Diagnostics market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Point-of-Care Molecular Diagnostics market type, application, player and country market segmentation data.
Chapters 8-9: Segmented the global Point-of-Care Molecular Diagnostics market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Point-of-Care Molecular Diagnostics industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
South America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Abbott Laboratories, Inc.
Roche Diagnostics
bioMérieux SA
Danaher Corporation (Beckman Coulter)
Cepheid (a subsidiary of Danaher Corporation)
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
Hologic, Inc.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company (BD)
GenMark Diagnostics, Inc.
Meridian Bioscience, Inc.
Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific)
Biocartis Group NV
QuantuMDx Group Limited

Types list
OTC
POC

Application list
Decentralized Labs
Hospitals
Homecare
Assisted Living Healthcare Facilities
Others

Table of Content

1 Point-of-Care Molecular Diagnostics Market Introduction and Overview
1.1 Point-of-Care Molecular Diagnostics Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
2.2 Point-of-Care Molecular Diagnostics Growth Trends Analysis by Regions
2.2.1 Point-of-Care Molecular Diagnostics Market Size by Regions: 2019 VS 2024 VS 2030
2.2.2 Point-of-Care Molecular Diagnostics Historic Market Size by Regions (2019-2024)
2.2.3 Point-of-Care Molecular Diagnostics Forecasted Market Size by Regions (2024-2030)
2.2.4 North America Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
2.2.5 Europe Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
2.2.6 Asia-Pacific Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
2.2.7 Latin America Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
2.2.8 Middle East & Africa Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
3 North America
3.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries
3.1.1 North America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
3.2 North America Point-of-Care Molecular Diagnostics Revenue by Players
3.3 North America Point-of-Care Molecular Diagnostics Revenue by Types
3.4 North America Point-of-Care Molecular Diagnostics Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Countries
4.1.1 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
4.2 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Players
4.3 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Types
4.4 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries
5.1.1 Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
5.2 Europe Point-of-Care Molecular Diagnostics Revenue by Players
5.3 Europe Point-of-Care Molecular Diagnostics Revenue by Types
5.4 Europe Point-of-Care Molecular Diagnostics Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America Point-of-Care Molecular Diagnostics Revenue by Countries
6.1.1 Latin America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
6.2 Latin America Point-of-Care Molecular Diagnostics Revenue by Players
6.3 Latin America Point-of-Care Molecular Diagnostics Revenue by Types
6.4 Latin America Point-of-Care Molecular Diagnostics Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Countries
7.1.1 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
7.2 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Players
7.3 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Types
7.4 Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global Point-of-Care Molecular Diagnostics Historical and Forecast Market Analysis by Type
8.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type
8.2 Global Point-of-Care Molecular Diagnostics Market Forecast by Type (2024-2030)
9 Global Point-of-Care Molecular Diagnostics Historical and Forecast Market Analysis by Application
9.1 Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2019-2024)
9.2 Point-of-Care Molecular Diagnostics Market Forecast by Application (2024-2030)
10 Point-of-Care Molecular Diagnostics Industry Dynamic Analysis
10.1 Point-of-Care Molecular Diagnostics Market Trends Analysis
10.2 Point-of-Care Molecular Diagnostics Market Drivers Analysis
10.3 Point-of-Care Molecular Diagnostics Market Challenges Analysis
10.4 Point-of-Care Molecular Diagnostics Market Restraints Analysis
10.5 Point-of-Care Molecular Diagnostics Industry Mergers & Acquisitions
10.6 Point-of-Care Molecular Diagnostics Industry New Entrants and Expansion Plans
11 Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Profile
11.1.2 Point-of-Care Molecular Diagnostics Product Overview
11.1.3 Abbott Laboratories, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.1.4 Abbott Laboratories, Inc. Business Overview
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Profile
11.2.2 Point-of-Care Molecular Diagnostics Product Overview
11.2.3 Roche Diagnostics Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.2.4 Roche Diagnostics Business Overview
11.3 bioMérieux SA
11.3.1 bioMérieux SA Company Profile
11.3.2 Point-of-Care Molecular Diagnostics Product Overview
11.3.3 bioMérieux SA Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.3.4 bioMérieux SA Business Overview
11.4 Danaher Corporation (Beckman Coulter)
11.4.1 Danaher Corporation (Beckman Coulter) Company Profile
11.4.2 Point-of-Care Molecular Diagnostics Product Overview
11.4.3 Danaher Corporation (Beckman Coulter) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.4.4 Danaher Corporation (Beckman Coulter) Business Overview
11.5 Cepheid (a subsidiary of Danaher Corporation)
11.5.1 Cepheid (a subsidiary of Danaher Corporation) Company Profile
11.5.2 Point-of-Care Molecular Diagnostics Product Overview
11.5.3 Cepheid (a subsidiary of Danaher Corporation) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.5.4 Cepheid (a subsidiary of Danaher Corporation) Business Overview
11.6 QIAGEN N.V.
11.6.1 QIAGEN N.V. Company Profile
11.6.2 Point-of-Care Molecular Diagnostics Product Overview
11.6.3 QIAGEN N.V. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.6.4 QIAGEN N.V. Business Overview
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Profile
11.7.2 Point-of-Care Molecular Diagnostics Product Overview
11.7.3 Thermo Fisher Scientific, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.7.4 Thermo Fisher Scientific, Inc. Business Overview
11.8 Hologic, Inc.
11.8.1 Hologic, Inc. Company Profile
11.8.2 Point-of-Care Molecular Diagnostics Product Overview
11.8.3 Hologic, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.8.4 Hologic, Inc. Business Overview
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Profile
11.9.2 Point-of-Care Molecular Diagnostics Product Overview
11.9.3 Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.9.4 Bio-Rad Laboratories, Inc. Business Overview
11.10 Becton, Dickinson and Company (BD)
11.10.1 Becton, Dickinson and Company (BD) Company Profile
11.10.2 Point-of-Care Molecular Diagnostics Product Overview
11.10.3 Becton, Dickinson and Company (BD) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.10.4 Becton, Dickinson and Company (BD) Business Overview
11.11 GenMark Diagnostics, Inc.
11.11.1 GenMark Diagnostics, Inc. Company Profile
11.11.2 Point-of-Care Molecular Diagnostics Product Overview
11.11.3 GenMark Diagnostics, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.11.4 GenMark Diagnostics, Inc. Business Overview
11.12 Meridian Bioscience, Inc.
11.12.1 Meridian Bioscience, Inc. Company Profile
11.12.2 Point-of-Care Molecular Diagnostics Product Overview
11.12.3 Meridian Bioscience, Inc. Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.12.4 Meridian Bioscience, Inc. Business Overview
11.13 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific)
11.13.1 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Company Profile
11.13.2 Point-of-Care Molecular Diagnostics Product Overview
11.13.3 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.13.4 Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Business Overview
11.14 Biocartis Group NV
11.14.1 Biocartis Group NV Company Profile
11.14.2 Point-of-Care Molecular Diagnostics Product Overview
11.14.3 Biocartis Group NV Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.14.4 Biocartis Group NV Business Overview
11.15 QuantuMDx Group Limited
11.15.1 QuantuMDx Group Limited Company Profile
11.15.2 Point-of-Care Molecular Diagnostics Product Overview
11.15.3 QuantuMDx Group Limited Point-of-Care Molecular Diagnostics Market Performance (2019-2024)
11.15.4 QuantuMDx Group Limited Business Overview
12 Research Findings and Conclusion

List of Tables and Figures

Figure Point-of-Care Molecular Diagnostics Picture
Table Product Definition of Point-of-Care Molecular Diagnostics
Table Global Point-of-Care Molecular Diagnostics Market Share by Type (2024 VS 2030)
Table Global Point-of-Care Molecular Diagnostics Market Share by Application (2024 VS 2030)
Figure Global Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
Table Point-of-Care Molecular Diagnostics Market Size by Regions: 2019 VS 2024 VS 2030
Table Point-of-Care Molecular Diagnostics Historic Market Size by Regions (2019-2024)
Table Point-of-Care Molecular Diagnostics Historic Market Share by Regions (2019-2024)
Table Point-of-Care Molecular Diagnostics Forecasted Market Size by Regions (2024-2030)
Table Point-of-Care Molecular Diagnostics Forecasted Market Share by Regions (2024-2030)
Figure North America Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
Figure Europe Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
Figure Asia-Pacific Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
Figure Latin America Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
Figure Middle East & Africa Point-of-Care Molecular Diagnostics Market Size & Forecast (2019-2030)
Table North America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2030)
Table North America Point-of-Care Molecular Diagnostics Revenue Share by Players 2023
Table North America Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table North America Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure United States Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Canada Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Table Asia-Pacific Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
Table Asia-Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2030)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue Share by Players 2023
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Asia Pacific Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure China Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Japan Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Korea Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Southeast Asia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure India Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Australia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Table Europe Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
Table Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2030)
Table Europe Point-of-Care Molecular Diagnostics Revenue Share by Players 2023
Table Europe Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Europe Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure Germany Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure France Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure UK Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Italy Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Russia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Spain Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Nordic Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Table Latin America Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2030)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Share by Players 2023
Table Latin America Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure Brazil Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Argentina Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Colombia Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Mexico Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Countries (2019-2030)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Countries (2019-2030)
Table Latin America Point-of-Care Molecular Diagnostics Revenue Share by Players 2023
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Types (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Types (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue by Applications (2019-2024)
Table Middle East & Africa Point-of-Care Molecular Diagnostics Revenue Market Share by Applications (2019-2024)
Figure Egypt Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure South Africa Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Israel Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure Turkey Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Figure GCC Countries Point-of-Care Molecular Diagnostics Revenue and Growth (2019-2030)
Table Global Point-of-Care Molecular Diagnostics Revenue and Market Size by Type (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Type (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Market Size Forecast by Type (2024-2030)
Table Global Point-of-Care Molecular Diagnostics Market Share Forecast by Type (2024-2030)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Size by Application (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2019-2024)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Size by Application (2024-2030)
Table Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application (2024-2030)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans
Table Abbott Laboratories, Inc. Profile
Table Product Overview
Table Abbott Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Abbott Laboratories, Inc. Revenue and Growth Rate
Figure Abbott Laboratories, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Roche Diagnostics Profile
Table Product Overview
Table Roche Diagnostics Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Roche Diagnostics Revenue and Growth Rate
Figure Roche Diagnostics Revenue Market Share 2019-2024
Table Business Overview
Table bioMérieux SA Profile
Table Product Overview
Table bioMérieux SA Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure bioMérieux SA Revenue and Growth Rate
Figure bioMérieux SA Revenue Market Share 2019-2024
Table Business Overview
Table Danaher Corporation (Beckman Coulter) Profile
Table Product Overview
Table Danaher Corporation (Beckman Coulter) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Danaher Corporation (Beckman Coulter) Revenue and Growth Rate
Figure Danaher Corporation (Beckman Coulter) Revenue Market Share 2019-2024
Table Business Overview
Table Cepheid (a subsidiary of Danaher Corporation) Profile
Table Product Overview
Table Cepheid (a subsidiary of Danaher Corporation) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Cepheid (a subsidiary of Danaher Corporation) Revenue and Growth Rate
Figure Cepheid (a subsidiary of Danaher Corporation) Revenue Market Share 2019-2024
Table Business Overview
Table QIAGEN N.V. Profile
Table Product Overview
Table QIAGEN N.V. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure QIAGEN N.V. Revenue and Growth Rate
Figure QIAGEN N.V. Revenue Market Share 2019-2024
Table Business Overview
Table Thermo Fisher Scientific, Inc. Profile
Table Product Overview
Table Thermo Fisher Scientific, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Thermo Fisher Scientific, Inc. Revenue and Growth Rate
Figure Thermo Fisher Scientific, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Hologic, Inc. Profile
Table Product Overview
Table Hologic, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Hologic, Inc. Revenue and Growth Rate
Figure Hologic, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Bio-Rad Laboratories, Inc. Profile
Table Product Overview
Table Bio-Rad Laboratories, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Bio-Rad Laboratories, Inc. Revenue and Growth Rate
Figure Bio-Rad Laboratories, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Becton, Dickinson and Company (BD) Profile
Table Product Overview
Table Becton, Dickinson and Company (BD) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Becton, Dickinson and Company (BD) Revenue and Growth Rate
Figure Becton, Dickinson and Company (BD) Revenue Market Share 2019-2024
Table Business Overview
Table GenMark Diagnostics, Inc. Profile
Table Product Overview
Table GenMark Diagnostics, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure GenMark Diagnostics, Inc. Revenue and Growth Rate
Figure GenMark Diagnostics, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Meridian Bioscience, Inc. Profile
Table Product Overview
Table Meridian Bioscience, Inc. Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Meridian Bioscience, Inc. Revenue and Growth Rate
Figure Meridian Bioscience, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Profile
Table Product Overview
Table Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Revenue and Growth Rate
Figure Mesa Biotech, Inc. (a subsidiary of Thermo Fisher Scientific) Revenue Market Share 2019-2024
Table Business Overview
Table Biocartis Group NV Profile
Table Product Overview
Table Biocartis Group NV Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure Biocartis Group NV Revenue and Growth Rate
Figure Biocartis Group NV Revenue Market Share 2019-2024
Table Business Overview
Table QuantuMDx Group Limited Profile
Table Product Overview
Table QuantuMDx Group Limited Point-of-Care Molecular Diagnostics Revenue, Gross and Gross Margin (2019-2024)
Figure QuantuMDx Group Limited Revenue and Growth Rate
Figure QuantuMDx Group Limited Revenue Market Share 2019-2024
Table Business Overview
Table Research Findings and Conclusion